Annual D&A
$33.00 K
+$1000.00+3.13%
31 December 2023
Summary:
Galectin Therapeutics annual depreciation & amortization is currently $33.00 thousand, with the most recent change of +$1000.00 (+3.13%) on 31 December 2023. During the last 3 years, it has fallen by -$3000.00 (-8.33%). GALT annual D&A is now -84.38% below its all-time high of $211.20 thousand, reached on 31 December 2002.GALT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$9000.00
$0.000.00%
30 September 2024
Summary:
Galectin Therapeutics quarterly depreciation & amortization is currently $9000.00, unchanged on 30 September 2024. Over the past year, it has increased by +$1000.00 (+12.50%). GALT quarterly D&A is now -95.04% below its all-time high of $181.50 thousand, reached on 31 December 2002.GALT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$36.00 K
+$1000.00+2.86%
30 September 2024
Summary:
Galectin Therapeutics TTM depreciation & amortization is currently $36.00 thousand, with the most recent change of +$1000.00 (+2.86%) on 30 September 2024. Over the past year, it has increased by +$4000.00 (+12.50%). GALT TTM D&A is now -85.02% below its all-time high of $240.40 thousand, reached on 30 September 2003.GALT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.1% | +12.5% | +12.5% |
| 3 y3 years | -8.3% | -10.0% | -7.7% |
| 5 y5 years | +100.0% | +12.5% | +38.5% |
GALT Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.5% | +3.1% | -71.9% | +156.3% | -33.3% | +260.0% |
| 5 y | 5 years | -19.5% | -71.9% | +156.3% | -33.3% | +260.0% | |
| alltime | all time | -84.4% | -95.0% | +114.7% | -85.0% | +528.6% |
Galectin Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9000.00(0.0%) | $36.00 K(+2.9%) |
| June 2024 | - | $9000.00(0.0%) | $35.00 K(+250.0%) |
| Mar 2024 | - | $9000.00(0.0%) | $10.00 K(-69.7%) |
| Dec 2023 | $33.00 K(+3.1%) | $9000.00(+12.5%) | $33.00 K(+3.1%) |
| Sept 2023 | - | $8000.00(-150.0%) | $32.00 K(+3.2%) |
| June 2023 | - | -$16.00 K(-150.0%) | $31.00 K(-42.6%) |
| Mar 2023 | - | $32.00 K(+300.0%) | $54.00 K(+68.8%) |
| Dec 2022 | $32.00 K(-22.0%) | $8000.00(+14.3%) | $32.00 K(-8.6%) |
| Sept 2022 | - | $7000.00(0.0%) | $35.00 K(-7.9%) |
| June 2022 | - | $7000.00(-30.0%) | $38.00 K(-7.3%) |
| Mar 2022 | - | $10.00 K(-9.1%) | $41.00 K(0.0%) |
| Dec 2021 | $41.00 K(+13.9%) | $11.00 K(+10.0%) | $41.00 K(+5.1%) |
| Sept 2021 | - | $10.00 K(0.0%) | $39.00 K(0.0%) |
| June 2021 | - | $10.00 K(0.0%) | $39.00 K(+5.4%) |
| Mar 2021 | - | $10.00 K(+11.1%) | $37.00 K(+2.8%) |
| Dec 2020 | $36.00 K(+2.9%) | $9000.00(-10.0%) | $36.00 K(0.0%) |
| Sept 2020 | - | $10.00 K(+25.0%) | $36.00 K(+5.9%) |
| June 2020 | - | $8000.00(-11.1%) | $34.00 K(0.0%) |
| Mar 2020 | - | $9000.00(0.0%) | $34.00 K(-2.9%) |
| Dec 2019 | $35.00 K(>+9900.0%) | $9000.00(+12.5%) | $35.00 K(+34.6%) |
| Sept 2019 | - | $8000.00(0.0%) | $26.00 K(+44.4%) |
| June 2019 | - | $8000.00(-20.0%) | $18.00 K(+80.0%) |
| Mar 2019 | - | $10.00 K(>+9900.0%) | $10.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2017 | $1000.00(-85.7%) | $0.00(0.0%) | $1000.00(-66.7%) |
| Sept 2017 | - | $0.00(0.0%) | $3000.00(-40.0%) |
| June 2017 | - | $0.00(-100.0%) | $5000.00(-28.6%) |
| Mar 2017 | - | $1000.00(-50.0%) | $7000.00(0.0%) |
| Dec 2016 | $7000.00(0.0%) | $2000.00(0.0%) | $7000.00(+16.7%) |
| Sept 2016 | - | $2000.00(0.0%) | $6000.00(0.0%) |
| June 2016 | - | $2000.00(+100.0%) | $6000.00(0.0%) |
| Mar 2016 | - | $1000.00(0.0%) | $6000.00(-14.3%) |
| Dec 2015 | $7000.00(-30.0%) | $1000.00(-50.0%) | $7000.00(-12.5%) |
| Sept 2015 | - | $2000.00(0.0%) | $8000.00(-11.1%) |
| June 2015 | - | $2000.00(0.0%) | $9000.00(-10.0%) |
| Mar 2015 | - | $2000.00(0.0%) | $10.00 K(0.0%) |
| Dec 2014 | $10.00 K(-16.7%) | $2000.00(-33.3%) | $10.00 K(-9.1%) |
| Sept 2014 | - | $3000.00(0.0%) | $11.00 K(0.0%) |
| June 2014 | - | $3000.00(+50.0%) | $11.00 K(0.0%) |
| Mar 2014 | - | $2000.00(-33.3%) | $11.00 K(-8.3%) |
| Dec 2013 | $12.00 K | $3000.00(0.0%) | $12.00 K(-7.7%) |
| Sept 2013 | - | $3000.00(0.0%) | $13.00 K(+18.2%) |
| June 2013 | - | $3000.00(0.0%) | $11.00 K(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $3000.00(-25.0%) | $10.00 K(+11.1%) |
| Dec 2012 | $9000.00(0.0%) | $4000.00(+300.0%) | $9000.00(+28.6%) |
| Sept 2012 | - | $1000.00(-50.0%) | $7000.00(-12.5%) |
| June 2012 | - | $2000.00(0.0%) | $8000.00(-11.1%) |
| Mar 2012 | - | $2000.00(0.0%) | $9000.00(0.0%) |
| Dec 2011 | $9000.00(-25.0%) | $2000.00(0.0%) | $9000.00(+12.5%) |
| Sept 2011 | - | $2000.00(-33.3%) | $8000.00(-11.1%) |
| June 2011 | - | $3000.00(+50.0%) | $9000.00(-10.0%) |
| Mar 2011 | - | $2000.00(+100.0%) | $10.00 K(-16.7%) |
| Dec 2010 | $12.00 K(-67.6%) | $1000.00(-66.7%) | $12.00 K(-33.3%) |
| Sept 2010 | - | $3000.00(-25.0%) | $18.00 K(-25.0%) |
| June 2010 | - | $4000.00(0.0%) | $24.00 K(-20.0%) |
| Mar 2010 | - | $4000.00(-42.9%) | $30.00 K(-18.9%) |
| Dec 2009 | $37.00 K(-24.5%) | $7000.00(-22.2%) | $37.00 K(-7.5%) |
| Sept 2009 | - | $9000.00(-10.0%) | $40.00 K(-7.0%) |
| June 2009 | - | $10.00 K(-9.1%) | $43.00 K(-4.4%) |
| Mar 2009 | - | $11.00 K(+10.0%) | $45.00 K(-8.2%) |
| Dec 2008 | $49.00 K(-23.4%) | $10.00 K(-16.7%) | $49.00 K(-9.3%) |
| Sept 2008 | - | $12.00 K(0.0%) | $54.00 K(-6.9%) |
| June 2008 | - | $12.00 K(-20.0%) | $58.00 K(-6.5%) |
| Mar 2008 | - | $15.00 K(0.0%) | $62.00 K(-3.1%) |
| Dec 2007 | $64.00 K(-4.5%) | $15.00 K(-6.3%) | $64.00 K(-4.5%) |
| Sept 2007 | - | $16.00 K(0.0%) | $67.00 K(+1.5%) |
| June 2007 | - | $16.00 K(-5.9%) | $66.00 K(+1.5%) |
| Mar 2007 | - | $17.00 K(-5.6%) | $65.00 K(-3.0%) |
| Dec 2006 | $67.00 K(-17.3%) | $18.00 K(+20.0%) | $67.00 K(-14.1%) |
| Sept 2006 | - | $15.00 K(0.0%) | $78.00 K(-6.0%) |
| June 2006 | - | $15.00 K(-21.1%) | $83.00 K(-1.2%) |
| Mar 2006 | - | $19.00 K(-34.5%) | $84.00 K(+3.7%) |
| Dec 2005 | $81.00 K(0.0%) | $29.00 K(+45.0%) | $81.00 K(+15.7%) |
| Sept 2005 | - | $20.00 K(+25.0%) | $70.00 K(+1.4%) |
| June 2005 | - | $16.00 K(0.0%) | $69.00 K(-921.4%) |
| Mar 2005 | - | $16.00 K(-11.1%) | -$8400.00(-110.4%) |
| Dec 2004 | $81.00 K(-9.0%) | $18.00 K(-5.3%) | $81.00 K(-13.0%) |
| Sept 2004 | - | $19.00 K(-130.9%) | $93.10 K(-3.1%) |
| June 2004 | - | -$61.40 K(-158.3%) | $96.10 K(-45.9%) |
| Mar 2004 | - | $105.40 K(+250.2%) | $177.60 K(+99.6%) |
| Dec 2003 | $89.00 K(-57.9%) | $30.10 K(+36.8%) | $89.00 K(-63.0%) |
| Sept 2003 | - | $22.00 K(+9.5%) | $240.40 K(+3.7%) |
| June 2003 | - | $20.10 K(+19.6%) | $231.90 K(+14.0%) |
| Mar 2003 | - | $16.80 K(-90.7%) | $203.50 K(-3.6%) |
| Dec 2002 | $211.20 K(+1631.1%) | $181.50 K(+1244.4%) | $211.20 K(+611.1%) |
| Sept 2002 | - | $13.50 K(-262.7%) | $29.70 K(+83.3%) |
| June 2002 | - | -$8300.00(-133.9%) | $16.20 K(-33.9%) |
| Mar 2002 | - | $24.50 K | $24.50 K |
| Dec 2001 | $12.20 K | - | - |
FAQ
- What is Galectin Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Galectin Therapeutics?
- What is Galectin Therapeutics annual D&A year-on-year change?
- What is Galectin Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly D&A year-on-year change?
- What is Galectin Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Galectin Therapeutics?
- What is Galectin Therapeutics TTM D&A year-on-year change?
What is Galectin Therapeutics annual depreciation & amortization?
The current annual D&A of GALT is $33.00 K
What is the all time high annual D&A for Galectin Therapeutics?
Galectin Therapeutics all-time high annual depreciation & amortization is $211.20 K
What is Galectin Therapeutics annual D&A year-on-year change?
Over the past year, GALT annual depreciation & amortization has changed by +$1000.00 (+3.12%)
What is Galectin Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GALT is $9000.00
What is the all time high quarterly D&A for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly depreciation & amortization is $181.50 K
What is Galectin Therapeutics quarterly D&A year-on-year change?
Over the past year, GALT quarterly depreciation & amortization has changed by +$1000.00 (+12.50%)
What is Galectin Therapeutics TTM depreciation & amortization?
The current TTM D&A of GALT is $36.00 K
What is the all time high TTM D&A for Galectin Therapeutics?
Galectin Therapeutics all-time high TTM depreciation & amortization is $240.40 K
What is Galectin Therapeutics TTM D&A year-on-year change?
Over the past year, GALT TTM depreciation & amortization has changed by +$4000.00 (+12.50%)